Round table: Principle of dosage selection for veterinary pharmaceutical products Bayesian approach in dosage selection NATIONAL VETERINARY S C H O O L.

Slides:



Advertisements
Similar presentations
Bayesian Learning & Estimation Theory
Advertisements

An introduction to population kinetics Didier Concordet NATIONAL VETERINARY SCHOOL Toulouse.
Monte Carlo simulations and bioequivalence of antimicrobial drugs NATIONAL VETERINARY S C H O O L T O U L O U S E July 2005 Didier Concordet.
What is the experimental unit in premix bioequivalence ? June 2010 Didier Concordet
INTRODUCTION TO MACHINE LEARNING Bayesian Estimation.
ECE 8443 – Pattern Recognition LECTURE 05: MAXIMUM LIKELIHOOD ESTIMATION Objectives: Discrete Features Maximum Likelihood Resources: D.H.S: Chapter 3 (Part.
MonteCarlo-Orlando Use of Monte Carlo simulations to select PK/PD breakpoints and therapeutic doses for antimicrobials in veterinary medicine PL.
Getting the Dose Right The View from Academia
Bayes Rule The product rule gives us two ways to factor a joint probability: Therefore, Why is this useful? –Can get diagnostic probability P(Cavity |
Sampling: Final and Initial Sample Size Determination
THE MEASUREMENT OF LD50 Definition An LD50 represents the individual dose required to kill 50 percent of a population of test animals. It is an index.
TNO orbit computation: analysing the observed population Jenni Virtanen Observatory, University of Helsinki Workshop on Transneptunian objects - Dynamical.
1 PK/PD modeling within regulatory submissions Is it used? Can it be used and if yes, where? Views from industry 24 September 2008.
Design of Individualized Dosage Regimes using a Bayesian Approach J. M. Laínez, G. Blau, L. Mockus, S. Orçun & G. V. Rekalitis May 2011.
Therapeutic Drug Monitoring (TDM)
Dose-Response Relationships Lesson 6. Dose & Drug Effects n Pharmacodynamics l what the drug does to the body n Effects of drug depends on dose n In general...
Bayes Rule How is this rule derived? Using Bayes rule for probabilistic inference: –P(Cause | Evidence): diagnostic probability –P(Evidence | Cause): causal.
AGC DSP AGC DSP Professor A G Constantinides© Estimation Theory We seek to determine from a set of data, a set of parameters such that their values would.
Basics of Statistical Estimation. Learning Probabilities: Classical Approach Simplest case: Flipping a thumbtack tails heads True probability  is unknown.
CSE 221: Probabilistic Analysis of Computer Systems Topics covered: Statistical inference (Sec. )
Machine Learning CMPT 726 Simon Fraser University
CSE 221: Probabilistic Analysis of Computer Systems Topics covered: Statistical inference.
Discriminant Analysis Objective Classify sample objects into two or more groups on the basis of a priori information.
Computer vision: models, learning and inference
458 Fitting models to data – III (More on Maximum Likelihood Estimation) Fish 458, Lecture 10.
Review: Probability Random variables, events Axioms of probability
Acute ischemic stroke (AIS) AISbrain artery Acute ischemic stroke (AIS) is a major cause of disability and death in adults. AIS is caused by a clot in.
For Clinical Pharmacist
Division of Pharmacokinetics and Drug Therapy Department of Pharmaceutical Biosciences Optimizing Dosing Strategies for Defined Therapeutic Targets Mats.
Exercise 5 Monte Carlo simulations, Bioequivalence and Withdrawal time
Clinical Pharmacy Part 2
7.4 – Sampling Distribution Statistic: a numerical descriptive measure of a sample Parameter: a numerical descriptive measure of a population.
EMEA London Pharmacokinetic- pharmacodynamic integration in veterinary drug development: an overview P.L. Toutain National Veterinary School ;Toulouse.
Therapeutic Equivalence & Active Control Clinical Trials Richard Simon, D.Sc. Chief, Biometric Research Branch National Cancer Institute.
Population Pharmacokinetic Characteristics of Levosulpiride and Terbinafine in Healthy Male Korean Volunteers Yong-Bok Lee College of Pharmacy and Institute.
Review: Probability Random variables, events Axioms of probability Atomic events Joint and marginal probability distributions Conditional probability distributions.
Rivaroxaban Has Predictable Pharmacokinetics (PK) and Pharmacodynamics (PD) When Given Once or Twice Daily for the Treatment of Acute, Proximal Deep Vein.
Ch15: Decision Theory & Bayesian Inference 15.1: INTRO: We are back to some theoretical statistics: 1.Decision Theory –Make decisions in the presence of.
1 Follow the three R’s: Respect for self, Respect for others and Responsibility for all your actions.
CSCI 121 Special Topics: Bayesian Networks Lecture #4: Learning in Bayes Nets.
1 Pharmacokinetics: Introduction Dr Mohammad Issa.
European Patients’ Academy on Therapeutic Innovation The key principles of pharmacology.
DEFINITIONS T1/2 & Tmax Cmax AUC 1st order kinetics
COMPUTER - ASSISTED INFUSION OF MUSCLE RELAXANTS Dr Valérie BILLARD.
Capture-recapture Models for Open Populations “Single-age Models” 6.13 UF-2015.
Evaluating the Safety of Antimicrobial New Animal Drugs with Regard to Their Microbiological Effects on Bacteria of Human Health Concern Qualitative Antimicrobial.
Office of Clinical Pharmacology and Biopharmaceutics IDSA/ISAP/FDA Workshop 4/16/04 Current Status of Dose Selection in Antimicrobial Drug Development.
Bayesian Brain Probabilistic Approaches to Neural Coding 1.1 A Probability Primer Bayesian Brain Probabilistic Approaches to Neural Coding 1.1 A Probability.
| 1 Application of a Bayesian strategy for monitoring multiple outcomes in early oncology clinical trials Application of a Bayesian strategy for monitoring.
Ch 1. Introduction Pattern Recognition and Machine Learning, C. M. Bishop, Updated by J.-H. Eom (2 nd round revision) Summarized by K.-I.
FREQUENCY DISTRIBUTION
CS479/679 Pattern Recognition Dr. George Bebis
Probability Theory and Parameter Estimation I
Introduction of Biopharmaceutics & Pharmacokinetics
ICS 280 Learning in Graphical Models
Ch3: Model Building through Regression
Parameter Estimation 主講人:虞台文.
BAYESIAN THEORY WITH ADAPTIVE METHOD OR DOSING WITH FEEDBACK
Special Topics In Scientific Computing
INTRODUCTION TO BAYESIAN THEORY
ANALYSIS OF POPULATION KINETIC DATA
Estimating Populations
Clinical Pharmacokinetics
Nat. Rev. Clin. Oncol. doi: /nrclinonc
'Linear Hierarchical Models'
Pattern Classification All materials in these slides were taken from Pattern Classification (2nd ed) by R. O. Duda, P. E. Hart and D. G. Stork, John.
The estimate of the proportion (“p-hat”) based on the sample can be a variety of values, and we don’t expect to get the same value every time, but the.
Therapeutic Drug Monitoring chapter 1 part 1
Drug-Receptor Interaction
Assessing similarity of curves: An application in assessing similarity between pediatric and adult exposure-response curves July 31, 2019 Yodit Seifu,
Presentation transcript:

Round table: Principle of dosage selection for veterinary pharmaceutical products Bayesian approach in dosage selection NATIONAL VETERINARY S C H O O L T O U L O U S E D. Concordet National Veterinary School Toulouse, France EAVPT Torino September 2006

Bayesian forecasting methods = Therapeutic drug monitoring

Why a bayesian forecasting method ? Consequence of PK Variability : the same dose gives different exposures Exposure Efficacy Toxicity

Why a bayesian forecasting method ? Consequence of PK Variability : the same dose gives different exposures Exposure Toxicity Efficacy We need to anticipate the "level" of exposure

How to predict exposure ? Exposure

How to predict exposure ? Exposure Covariate : e.g. Age POPULATION PK Cannot be predicted with covariates Need further information

The bayesian approach Same dose animals with the same age A blood sample at this time Probably a high exposure a priori information

The bayesian approach Same dose animals with the same age A blood sample at this time Probably a small exposure a priori information

The bayesian approach Same dose animals with the same age A blood sample at this time Exposure ? a priori information

Why population information is needed ? A blood sample at this time Exposure ? Time Concentration

The bayesian approach Same dose animals with the same age A blood sample at this time

The bayesian approach Same dose animals with the same age A blood sample at this time Exposure Frequency

The a posteriori distribution Distribution of exposure for animals that received the same dose have the same age have the same drug concentation at the sampling time Exposure Maximum a posteriori (MAP) = Bayesian estimate = most common exposure Frequency

The a priori information Same dose animals with the same age A blood sample at this time Exposure Frequency

The a priori information Same dose animals with the same age A blood sample at this time Exposure Frequency

The a priori information Same dose animals with the same age A blood sample at this time Exposure Frequency

How to predict exposure ? Exposure Covariate : e.g. Age POP. PK

How to predict exposure ? Exposure Covariate : e.g. Age POP. PK POP. PK + 1 concentration

How to predict exposure ? Exposure Covariate : e.g. Age POP. PK POP. PK + 1 concentration POP. PK + 2 concentrations

Problem of highly variable drugs ? Time Concentration 1 st Administration: fixed dose A blood sample at this time

Problem of highly variable drugs ? Large inter-occasion variability Time Concentration 2 nd Administration: same animal, same dose as 1 st A blood sample at this time

How does it work ? j th concentration measured on the i th animal j th sample time of the i th animal A population model

How does it work ? A set of concentrations on THE animal : (t 1, Z 1 ), (t 2, Z 2 ), … Maximize the a posteriori likelihood Minimize

To summarize Bayesian forecasting can be useful for: pets touchy drugs (narrow therapeutic index) It requires: results of a pop PK study some concentrations on the animal a recent computer Can’t work for large inter-occasion variability